Everolimus-Based Immunosuppression in Liver Transplant Recipients

被引:2
|
作者
Saliba, F. [1 ]
机构
[1] Hop Paul Brousse, AP HP, Ctr Hepatobiliaire, INSERM,Unite 1193, Villejuif, France
关键词
D O I
10.1111/ajt.14388
中图分类号
R61 [外科手术学];
学科分类号
摘要
引用
收藏
页码:2489 / 2489
页数:1
相关论文
共 50 条
  • [41] Everolimus-Based Immunosuppression Therapy for BK Virus Nephropathy
    Polanco, N.
    Gonzalez Monte, E.
    Folgueira, M. D.
    Morales, E.
    Gutierrez Martinez, E.
    Bengoa, I.
    Hernandez, A.
    Morales, J. M.
    Praga, M.
    Andres, A.
    TRANSPLANTATION PROCEEDINGS, 2015, 47 (01) : 57 - 61
  • [42] Everolimus immunosuppression reduces the serum expression of fibrosis markers in liver transplant recipients
    Ainhoa Fernández-Yunquera
    Cristina Ripoll
    Rafael Ba?ares
    Marta Puerto
    Diego Rincón
    Ismael Yepes
    Vega Catalina
    Magdalena Salcedo
    World Journal of Transplantation, 2014, (02) : 133 - 140
  • [43] EVEROLIMUS IMMUNOSUPPRESSION REDUCES SERUM EXPRESSION OF FIBROSIS MARKERS IN LIVER TRANSPLANT RECIPIENTS
    Yunquera, A. F.
    Plaza, M. M. S.
    Ripoll, C.
    Puerto, M.
    Rincon, D.
    Yepes, I.
    Catalina, M. V.
    Senosiain, M.
    Matilla, A.
    Clemente, G.
    Banares, R.
    JOURNAL OF HEPATOLOGY, 2011, 54 : S237 - S237
  • [44] EFFECT OF TACROLIMUS EXPOSURE ON EVEROLIMUS-BASED IMMUNOSUPPRESSION IN DE NOVO KIDNEY TRANSPLANT RECIPIENTS: A 24-MONTH ANALYSIS FROM TRANSFORM STUDY
    Citterio, Franco
    Peddi, V. Ram
    Qazi, Yasir
    Kim, Dean
    Vincenti, Flavio
    Berger, Stefan
    Sommerer, Claudia
    Gawai, Apurva
    Hernandez-Gutierrez, Maria-Pilar
    Bernhardt, Peter
    Oberbauer, Rainer
    TRANSPLANT INTERNATIONAL, 2021, 34 : 254 - 255
  • [45] Cognitive functioning among heart transplant recipients, receiving calcineurin inhibitor-free, everolimus-based immunosuppression since the early postoperative phase
    Burker, B. S.
    Andersson, S.
    Gullestad, L.
    Gude, E.
    Relbo, A.
    Grov, I.
    Malt, U. F.
    Andreassen, A.
    Fiane, A. E.
    Haraldsen, I. R.
    JOURNAL OF PSYCHOSOMATIC RESEARCH, 2015, 78 (06) : 595 - 596
  • [46] EVEROLIMUS AS THE ONLY COMPONENT OF LONG-TERM MAINTENANCE IMMUNOSUPPRESSION AT LIVER TRANSPLANT RECIPIENTS
    Salienko, Anastasia
    Syutkin, Vladimir E.
    Novruzbekov, Murad
    HEPATOLOGY, 2021, 74 : 877A - 878A
  • [47] Circulating delta-like Notch ligand 1 is correlated with cardiac allograft vasculopathy and suppressed in heart transplant recipients on everolimus-based immunosuppression
    Norum, Hilde M.
    Michelsen, Annika E.
    Lekva, Tove
    Arora, Satish
    Otterdal, Kari
    Olsen, Maria Belland
    Kong, Xiang Yi
    Gude, Einar
    Andreassen, Arne K.
    Solbu, Dag
    Karason, Kristjan
    Dellgren, Goran
    Gullestad, Lars
    Aukrust, Pal
    Ueland, Thor
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 (04) : 1050 - 1060
  • [48] EARLY EVEROLIMUS-BASED TACROLIMUS REDUCTION IN DE NOVO LIVER TRANSPLANT RECIPIENTS: DESIGN AND BASELINE DATA FROM HEPHAISTOS STUDY
    Nashan, B.
    Schemmer, P.
    Braun, F.
    Dworak, M.
    Wimmer, P.
    Schlitt, H.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S850 - S850
  • [49] De Novo Everolimus-Based Therapy in Renal Transplant Recipients: Effect on Proteinuria and Renal Prognosis
    Loriga, G.
    Ciccarese, M.
    Pala, P. G.
    Satta, R. P.
    Fanelli, V.
    Manca, M. L.
    Serra, G.
    Dessole, P.
    Cossu, M.
    TRANSPLANTATION PROCEEDINGS, 2010, 42 (04) : 1297 - 1302
  • [50] Five-year Outcome of an Early Everolimus-based Quadruple Immunosuppression in Lung Transplant Recipients: Follow-up of the 4EVERLUNG Study
    Kneidinger, Nikolaus
    Valtin, Christina
    Hettich, Ina
    Frye, Bjorn Christian
    Wald, Alexandra
    Wilkens, Heinrike
    Bessa, Vasiliki
    Gottlieb, Jens
    TRANSPLANTATION, 2022, 106 (09) : 1867 - 1874